{
    "2020-06-07": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AstraZeneca Reportedly Talked to Gilead About a Merger. Why Thereâ€™s Reason to Be Skeptical.",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Gilead",
                        "Merger",
                        "Skeptical"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AstraZeneca Ponders a Huge $240 Billion Gilead Gamble",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Gilead",
                        "Huge",
                        "$240 Billion",
                        "Gamble"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Is Moderna Really the Leader in the COVID-19 Vaccine Race?",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Leader",
                        "COVID-19",
                        "Vaccine",
                        "Race"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}